Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase [...]

Continue reading about Innate Therapeutics Receives Funding For Clinical Trial Of Progressive Multiple Sclerosis Therapeutic

Allos Therapeutics Reports First Quarter 2010 Financial Results WESTMINSTER, Colo.—-Allos Therapeutics, Inc. today reported financial results for the first quarter ended March 31, 2010. Read more on Business Wire via Yahoo! Finance

Continue reading about Allos Therapeutics Reports First Quarter 2010 Financial Results